Cara Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Cara Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2012 to 2023.
  • Cara Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Cara Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $0.000.
  • Cara Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Cara Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Cara Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $0 +$691K Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 -$691K +$125K +15.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 -$816K -$427K -110% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$389K -$185K -90.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$204K +$264K +56.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$468K -$71K -17.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 -$397K -$196K -97.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 -$201K -$171K -570% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 -$30K +$1K +3.23% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-11
2012 -$31K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.